Insys Therapeutics, Inc. Deferred Revenue
Insys Therapeutics, Inc. had Deferred Revenue of $1.11 million as of 2017-12-31, per its 10-Q filed 2018-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-11-09
- 2017-12-31: Deferred Revenue, Current $1.11M.
- 2017-09-30: Deferred Revenue, Current $940.00K.
- 2013-09-30: Deferred Revenue, Current $1.51M.
- 2013-06-30: Deferred Revenue, Current $2.82M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2017-12-31 | $1.11M 10-Q · filed 2018-11-09 |
| 2017-09-30 | $940.00K 10-Q · filed 2017-11-03 |
| 2013-09-30 | $1.51M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $2.82M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $3.61M 10-Q · filed 2013-06-05 |
| 2012-12-31 | $3.77M 10-K · filed 2014-03-05 |